These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20625868)

  • 1. Cardiovascular drug discovery in the academic setting: building infrastructure, harnessing strengths, and seeking synergies.
    Gardell SJ; Roth GP; Kelly DP
    J Cardiovasc Transl Res; 2010 Oct; 3(5):431-7. PubMed ID: 20625868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
    Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery in a multidimensional world: systems, patterns, and networks.
    Dudley JT; Schadt E; Sirota M; Butte AJ; Ashley E
    J Cardiovasc Transl Res; 2010 Oct; 3(5):438-47. PubMed ID: 20677029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking 'academic' drug discovery: the Manchester Institute perspective.
    Jordan AM; Waddell ID; Ogilvie DJ
    Drug Discov Today; 2015 May; 20(5):525-35. PubMed ID: 25542353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Academic-Industrial Complexity: Failure to Launch.
    Levin LA; Behar-Cohen F
    Trends Pharmacol Sci; 2017 Dec; 38(12):1052-1060. PubMed ID: 29111229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in the Development of Novel Cardiovascular Therapies.
    Hwang TJ; Kesselheim AS
    Clin Pharmacol Ther; 2017 Aug; 102(2):194-196. PubMed ID: 28643861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCSF Small Molecule Discovery Center: innovation, collaboration and chemical biology in the Bay Area.
    Arkin MR; Ang KK; Chen S; Davies J; Merron C; Tang Y; Wilson CG; Renslo AR
    Comb Chem High Throughput Screen; 2014 May; 17(4):333-42. PubMed ID: 24661212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crowdsourcing in pharma: a strategic framework.
    Bentzien J; Bharadwaj R; Thompson DC
    Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular research is thriving in China.
    Gao F; Sun RJ; Ji Y; Yang BF
    Br J Pharmacol; 2015 Dec; 172(23):5430-4. PubMed ID: 24962428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches.
    Galis ZS; Black JB; Skarlatos SI
    Circ Res; 2013 Apr; 112(9):1212-8. PubMed ID: 23620235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
    Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
    Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EATRIS, a vision for translational research in Europe.
    Becker R; van Dongen GA
    J Cardiovasc Transl Res; 2011 Jun; 4(3):231-7. PubMed ID: 21544739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
    Matter A; Keller TH
    Drug Discov Today; 2008 Apr; 13(7-8):347-52. PubMed ID: 18405848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an evidence-based practice and research collaborative among urban hospitals.
    Weeks SM; Marshall J; Burns P
    Nurs Clin North Am; 2009 Mar; 44(1):27-31, ix-x. PubMed ID: 19167546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anecdotes from ITMAT: building capacity for translational science.
    FitzGerald GA
    Clin Pharmacol Ther; 2013 Sep; 94(3):291-6. PubMed ID: 23963214
    [No Abstract]   [Full Text] [Related]  

  • 20. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.